News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

J. Michael Bostwick, MD

Dr Bostwick is professor of psychiatry at the Mayo Clinic.

Articles by J. Michael Bostwick, MD

Let’s Ask the Right Questions About Medical Aid in Dying

ByBrent Michael Kious, MD, PhD,Margaret Battin, PhD,J. Michael Bostwick, MD,Lewis M. Cohen, MD,Elizabeth Morrison MD,Thomas Strouse, MD,Stuart Youngner, MD

August 11th 2021

Some patients are intractably and maybe even irredeemably ill. What should be done for them?

A New Question in End-of-Life Ethics

ByThomas Strouse, MD,Margaret Battin, PhD,J. Michael Bostwick, MD,Lewis M. Cohen, MD,Elizabeth Morrison MD,Stuart Youngner, MD

June 11th 2021

Patients with terminal illnesses may choose to refuse treatment or even hasten their own deaths, but is that the same thing as suicide?

Latest Updated Articles

Trending on Psychiatric Times

Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder

When Symptoms Are Not Necessarily Signs of Illness: Rethinking Synchronicity in Psychiatry

Study Finds Semaglutide Is Associated With Improved Cognitive Function in Individuals With Psychiatric Disorders

A Critical Catch: Catatonia Due to Multiple General Medical Conditions

Should Solitude Be a Psychiatric Value?

© 2025 MJH Life Sciences^®

All rights reserved.